Should I Buy VSTS? VSTS 2026 Analysis

Should You Buy Vestis Corp (VSTS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

7.180

1 Day change

5.12%

52 Week Range

13.900

Analysis Updated At

2026/01/30

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now. Price action and momentum are weak (negative, expanding MACD), options flow is sharply bearish on the day (put-volume dominated), and the only fresh news is legal/governance-related rather than business-positive. With earnings coming soon (2026-02-10 pre-market) and the stock sitting just above nearby support (~6.35), the risk/reward for an impatient entry is unattractive today—best stance is to stay on the sidelines (hold/avoid new buys).

Technical Analysis

Trend/momentum is soft-to-bearish. The MACD histogram is -0.0285 and negatively expanding, signaling downside momentum is building rather than stabilizing. RSI(6) at ~44.5 is neutral but skewed weak (not oversold enough to suggest a reliable bounce). Moving averages are converging, which often precedes a larger move; given the negative MACD, the bias is to the downside unless price quickly reclaims the pivot. Key levels: pivot 6.654 (price 6.53 is below it = weak), first support 6.349 then 6.16; resistance 6.654 then 6.96. Near-term setup looks like 'below pivot, drifting toward support' rather than a clean breakout buy.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock recently.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

Options sentiment is mixed structurally but bearish tactically: open interest put/call at 0.51 suggests more call OI than puts overall (positioning not heavily bearish), but today’s option volume put/call at 19.85 is extremely put-dominated, pointing to strong near-term downside hedging/speculation. Implied volatility is very elevated (30D IV ~94 vs historical vol ~42.7; IV percentile ~84), meaning the options market is pricing large moves—often seen around stress or event risk (earnings soon) and not typically a clean 'comfortable' dip-buy environment for impatient entries.

Technical Summary

Sell

Buy

Positive Catalysts

- Upcoming earnings catalyst: QDEC 2025 earnings on 2026-02-10 pre-market (consensus EPS est. 0.06), which could re-rate the stock if execution/guidance beats.
- Revenue grew in the latest reported quarter (2025/Q4 +4.05% YoY).
- Management/Street framing suggests 2026 as a “foundational year” for rebuild (could support a turnaround narrative if early KPIs improve).

Neutral/Negative Catalysts

with a negatively expanding MACD histogram.

Financial Performance

Latest quarter: 2025/Q4. Revenue increased to $712.0M (+4.05% YoY), while profitability remains weak: net income was still negative (-$12.55M) though improved YoY, and EPS was -0.10 (also improved YoY). The key issue is margin compression: gross margin dropped to 20.16% (-14.68% YoY), indicating cost pressure/price mix challenges despite top-line growth—this is not the kind of clean accelerating fundamental trend that typically supports an aggressive buy-now decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent changes show modest target bumps but still cautious ratings:

JPMorgan (2025-12-03): raised PT to $6 from $5.50, keeps Underweight; frames 2026 as a rebuild/foundational year after a challenging 2025.
Baird (2025-12-02): raised PT to $6.50 from $5, keeps Neutral; notes Q4 results not great and guidance improved but appears somewhat high. Wall Street pro view: a turnaround is possible and expectations may be low enough for upside surprises. Con view: execution risk is high (margin pressure, recent weak results), and targets sit around current price—implying limited conviction for near-term upside. Ownership/flow checks: hedge funds and insiders are neutral (no notable trend). No recent congress trading data, and no reported politician/influential figure transactions in the provided data.

5 Analyst Rating

Wall Street analysts forecast VSTS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for VSTS is 5.7 USD with a low forecast of 5 USD and a high forecast of 6.5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

2 Hold

3 Sell

Moderate Sell

Current: 6.830

Low

Averages

5.7

High

6.5

Current: 6.830

Low

Averages

5.7

High

6.5

JPMorgan

Underweight

maintain

AI Analysis

2025-12-03

Reason

JPMorgan

Price Target

AI Analysis

2025-12-03

maintain

Underweight

Reason

JPMorgan raised the firm's price target on Vestis to $6 from $5.50 and keeps an Underweight rating on the shares. The firm says that after a challenging 2025, the company views 2026 as a "foundational year" for rebuild.

Baird

Neutral

maintain

2025-12-02

Reason

Baird

Price Target

2025-12-02

maintain

Neutral

Reason

Baird raised the firm's price target on Vestis to $6.50 from $5 and keeps a Neutral rating on the shares. The firm updated its model following not great Q4 results and where guidance is better but seems a bit high.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for VSTS

Unlock Now

VSTS Should I Buy

VSTS Should I Buy

Should You Buy Vestis Corp (VSTS) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch